Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts by Park, Jihwan et al.
RESEARCH ARTICLE
Identification of the early and late responder
genes during the generation of induced
pluripotent stem cells from mouse fibroblasts
Jihwan Park1☯, Yoo-Wook Kwon2,3☯, Seokjin Ham1, Chang-Pyo Hong1, Seonghye Seo1,
Moon Kyung Choe1, So-I Shin1, Choon-Soo Lee2, Hyo-Soo Kim2,3,4, Tae-Young Roh1,5*
1 Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang,
Republic of Korea, 2 National Research Laboratory for Stem Cell Niche, Seoul National University College of
Medicine, Seoul, Republic of Korea, 3 Innovative Research Institute for Cell Therapy and Cardiovascular
Center & Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea,
4 Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence
Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul,
Republic of Korea, 5 Division of Integrative Biosciences and Biotechnology, Pohang University of Science
and Technology (POSTECH), Pohang, Republic of Korea




The generation of induced pluripotent stem cell (iPSC), a substitute for embryonic stem cell
(ESC), requires the proper orchestration of a transcription program at the chromatin level.
Our recent approach for the induction of pluripotent stem cells from fibroblasts using protein
extracts from mouse ESCs could overcome the potential tumorigenicity risks associated
with random retroviral integration. Here, we examine the epigenetic modifications and the
transcriptome of two types of iPSC and of partially reprogrammed iPSCs (iPSCp) generated
independently from adult cardiac and skin fibroblasts to assess any perturbations of the
transcription program during reprogramming.
Results
The comparative dissection of the transcription profiles and histone modification patterns at
lysines 4 and 27 of histone H3 of the iPSC, iPSCp, ESC, and somatic cells revealed that the
iPSC was almost completely comparable to the ESC, regardless of their origins, whereas
the genes of the iPSCp were dysregulated to a larger extent. Regardless of the origins of
the somatic cells, the fibroblasts induced using the ESC protein extracts appear to be
completely reprogrammed into pluripotent cells, although they show unshared marginal dif-
ferences in their gene expression programs, which may not affect the maintenance of stem-
ness. A comparative investigation of the iPSCp generated by unwanted reprogramming
showed that the two groups of genes on the pathway from somatic cells to iPSC might func-
tion as sequential reprogramming-competent early and late responders to the induction
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stimulus. Moreover, some of the divergent genes expressed only in the iPSCp were associ-
ated with many tumor-related pathways.
Conclusions
Faithful transcriptional reprogramming should follow epigenetic alterations to generate
induced pluripotent stem cells from somatic cells. This genome-wide comparison enabled
us to define the early and late responder genes during the cell reprogramming process to
iPSC. Our results indicate that the cellular responsiveness to external stimuli should be pre-
determined and sequentially orchestrated through the tight modulation of the chromatin
environment during cell reprogramming to prevent unexpected reprogramming.
Introduction
iPSCs generated from somatic cells are attractive sources for the development of patient-spe-
cific regenerative medicines, as well as for drug discovery and toxicology testing in the near
future. The first reprogramming of somatic cells into a pluripotent state was achieved using
the ectopic expression of key transcription factors, such as Oct4, Sox2, c-Myc and Klf4 [1–3].
Great efforts have been made to improve the reprogramming efficiency and to reduce the
potential risks arising from viral transduction. Various reprogramming protocols using non-
integrating adenoviruses, plasmid transfection, recombinant proteins, and ESC-derived pro-
tein extracts have been introduced [4–7]. In addition, iPSC lines have been generated from
multiple cell types, including hematopoietic progenitors, neural cells, pancreas, stomach and
liver cells, fibroblasts, and keratinocytes [8–13].
The post translational modifications of histones, such as methylation, acetylation, phos-
phorylation, and ubiquitination, have been identified as the key regulatory mechanisms of the
gene expression program. The high resolution genome-wide maps of diverse histone modifica-
tions have presented clear evidence of their involvement in many genomic functions and chro-
matin organization [14–18]. Among the many histone modifications studied to date, the roles
of histone H3 tri-methylations at lysine 4 (H3K4me3) and lysine 27 (H3K27me3) are well-
characterized regarding gene activation, repression, and a poised chromatin state [19–22]. All
functional DNA elements marked by histone modifications have been extensively annotated
by several international consortia, such as the Encyclopedia of DNA Elements (ENCODE), the
NIH Roadmap Epigenomics Program, and the International Human Epigenome Consortium,
etc., and by many individual groups, including ours [16, 23–28]. Moreover, the bivalent chro-
matin state characterized by the coexistence of two counteracting histone modifications,
H3K4me3 and H3K27me3, represents the poised chromatin state of essential genes responsi-
ble for maintaining the stemness and differentiation potential of stem cells, as well as the cell
type-specific genes of differentiated cells, such as T cells [15, 29–32]. A recent study also
showed that epigenetic reprogramming should precede transcriptional re-activation and full
reprogramming [33]. Various lines of research evidence indicate that epigenetic reprogram-
ming is an essential process in the induction of pluripotent stem cells.
It has been shown that iPSCs globally recover ESC-like epigenetic states and ESC-like gene
expression patterns [19, 34, 35]. However, a couple of studies indicated that the iPSCs have a
certain degree of variance of their epigenomes and transcriptomes compared with ESCs [36,
37]. Some recent reports have proposed that the variances between the two cell types are labo-
ratory-specific, implying that the discrepancies observed in the previous studies might be due
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to the experimental variation or the different cell culture condition [38–40]. In addition, the
characterization of 20 human ESC lines and 12 iPSC lines revealed their global similarity and
the existence of cell-line-specific outliers that may cause unwanted differentiation [41]. It
has also been reported that partially reprogrammed cells that achieve a stable state between
somatic cells and fully reprogrammed cells could be generated using the ectopic expression of
defined factors [19, 42]. A proposed reprogramming mechanism is the step-wise transition
from the differentiated to the pluripotent state, as follows: 1) induction of proliferation and
down-regulation of fibroblast-specific transcription, 2) acquisition of epithelial cell character
and the activation of some ESC markers, and 3) final activation of pluripotency-related genes
[19, 43]. The immunofluorescence labelling study using partial iPSCs showed that a decrease
in the number of heterochromatin foci precedes Nanog expression and euchromatin reorgani-
zation during reprogramming [44]. It is also shown that somatic cell-specific genes are more
efficiently suppressed and that ESC-specific transcriptional regulators are poorly repro-
grammed in partial iPSCs [42]
Previously, we have generated fully reprogrammed iPSCs from adult mouse skin and car-
diac fibroblasts using a single treatment of mouse ESC-derived soluble proteins. Without
genetic manipulation or foreign DNA, the somatic cells lost their character and became ESC-
like cells, which were shown to be truly de-differentiated iPSCs using many different methods
[7]. Interestingly, only cellular proteins extracted from C57BL/6 ESCs could be successfully
reprogrammed into iPSCs, but not those from E14 ESCs from a genetic background of 129.
The comparative proteomic analysis of iPSC and mESC showed that the reprogramming-com-
petent C57BL/6-ESC expressed large amounts of proteins regulating protein synthesis and
metabolism [45]. Meanwhile, the incomplete reprogramming of somatic cells gave rise to par-
tial iPSCs (iPSCps) due to unexpected transcriptional control. To further assess the protein-
based iPSCs, we obtained genome-wide profiles of histones H3K4me3 and H3K27me3 using
ChIP-Seq; we also measured the gene expression levels of two types of iPSCs from cardiac and
skin fibroblasts, mouse ESC and iPSCp from skin fibroblasts. Without a doubt, the chromatin
states were dramatically changed during reprogramming into the pluripotent state, and the
epigenetic modifications were accordingly associated with the changes of gene expression. The
comparative analysis revealed that the iPSC acquired the pluripotent state epigenetically and
transcriptionally. By focusing on the iPSCp, we could identify the reprogramming-competent
responder genes, and we categorized them into the early and late responders responsible for
explaining the step-wise reprogramming process. Our results could provide insights into the
functional understanding of the epigenetic modifications involved in the differential respon-
siveness of genes during the induction of pluripotency.
Materials and methods
Cell culture and reprogramming
All protocols for stem cell culture and animal treatment were previously established [7]. The
C57BL/6-background mouse ES cells (SCRC-1002, American Type Culture Cells (ATCC))
were cultured with a Mitomycin C-treated (Sigma-Aldrich, St. Louis, MO) STO feeder cell
layer on 0.1% gelatin-coated tissue culture dishes (Sigma-Aldrich, St. Louis, MO). The adult
cardiac fibroblasts (cFB) were prepared using the enzymatic digestion of the hearts harvested
from 8-week-old C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) and were incu-
bated with anti-c-kit microbeads (Miltenyi Biotec, Auburn, CA). The c-kit-negative cardiac
fibroblast cells were cultured for at least 4 passages with Dulbecco’s Modified Eagle’s Medium
(DMEM) containing 10% fetal bovine serum (FBS) and antibiotics. The skin fibroblast, sFB
was primarily cultured from the dermis of 8-week-old C57BL/6 and sFB-G from C57BL/6
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mice harboring Oct4-promoter-GFP or Actin-promoter-GFP from the Jackson Laboratory,
Bar Harbor, ME. Feeder cell-free ES cells and protein-iPS cells were harvested and used to pre-
pare chromatin and isolate mRNAs. The C56BL/6 ES cells were permeabilized using streptoly-
sin O (Sigma-Aldrich, St. Louis, MO), and the soluble proteins were extracted. After the
fibroblasts were treated with the ES cell protein extract, the primary colonies were observed,
reseeded onto an STO feeder layer, and subcultured. Passage 5 to 7 cells (culture days 45–55)
were used to obtain enough number of cells preparing chromatin and RNA. The partial iPS
cells, which show similar morphologies to the ES cell colonies at early passages but have differ-
ent shapes after later passages, were collected. All animal experiments were performed after
receiving approval from the Institutional Animal Care and Use Committee (IACUC) of the
Clinical Research Institute of Seoul National University Hospital, Korea.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed according to our previous publications [16,
25]. Briefly, native mononucleosome-sized chromatin was prepared using Microccocal Nucle-
ase digestion (Sigma, St. Louis, MO) in an ice-cold digestion buffer (50 mM Tris-HCI, pH 7.6,
1 mM CaCl2, 0.2% Triton X-100, 5 mM butyrate, 1 x proteinase inhibitor cocktail, and 0.5
mM PMSF). The chromatin was immunoprecipitated with antibodies specific to H3K4me3
(ab8580, Abcam, Cambridge, UK) and H3K27me3 (07–449, Millipore, Billerica, MA) in RIPA
buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 0.1% SDS, 0.1% Na-Deoxycholate, and 1% Triton
X-100). The proteinase K-treated DNA was purified using phenol/chloroform extraction and
dissolved in TE buffer. The enrichment of the purified DNA was validated using PCR.
DNA library construction for high-throughput sequencing and ChIP-Seq
analysis
The sequencing library was generated using the manufacturer’s instructions (Illumina, San
Diego, CA), with some modifications [25]. After completing the sequencing, the image analy-
sis, base calling, and alignment were performed using CASAVA 1.6 (Illumina, San Diego, CA).
The sequence reads were mapped onto the mouse reference genome (NCBI37/mm9). The
sequence data were deposited into the Sequence Read Archive (SRA) at the National Center
for Biotechnical Information (NCBI) (GSE58965). To quantitate the enrichment of H3K4me3
and H3K27me3 in each gene, the tag density was calculated for the gene loci. The normalized
tag densities of a 200-bp window were used to compare the distributions of the histone enrich-
ment around the gene transcription start site (TSS) of all 22,584 RefSeq genes. To compare the
ChIP-Seq data sets generated by different laboratories, we downloaded the histone modifica-
tion ChIP-Seq data from the NCBI SRA database (GSE12241 and GSE15519).
Gene expression analysis
The gene expression profiling was performed using Affymetrix GeneChip1 Mouse Gene 1.0
ST oligonucleotide arrays (Affymetrix, Santa Clara, CA) and Mouse Whole-genome Bead-
Chips (Illumina, San Diego, CA). The sample was prepared according to the manufacturer’s
instructions. After selecting valid probes, 15,608 annotated genes were used for the compara-
tive analysis. To identify the differentially expressed genes, one-way ANOVA test was used
with the following criteria: p-value< 0.01, and fold change 2. Public microarray data were
downloaded from the NCBI GEO database (GSE13770 [7], GSE24930 [46], GSE17004 [47],
GSE27814 [48], GSE22908 [49], GSE24046 [50], and GSE27087 [51], GSE10871 [19],
GSE45352 [43]). Data sets from different labs were quantile-normalized for the comparison.
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After removing the control probes, the hierarchical clustering with Euclidean distance and
complete linkage clustering was performed.
Results
Global chromatin signatures of somatic and pluripotent cells
The primary fibroblast cells were isolated from mouse C57BL/6 strain and cell reprogram-
ming was performed by treating with protein extracts from C57BL/6-ESC. The epigenetic
and transcriptional statuses were examined using the isolated mono-nucleosomes and
mRNAs from cFB and its iPSCs (iPSC1), sFB and its iPSCs (iPSC2), and sFB-G and its par-
tial iPSC (iPSCp1 and iPSCp2); all reprogramming was performed using a one-time treat-
ment of the somatic cells with the protein-extracts from mouse ESCs (Fig 1A). On the
pathway to pluripotency, all genes might not change their epigenetic profile and expression
patterns at the same time. To validate this hypothesis, two partially reprogrammed cells,
iPSCp1 and iPSCp2, were obtained by selecting cell masses that had a different morphology
from the mESCs at later passages. Using ChIP-Seq with histone H3K4me3 and H3K27me3
antibodies, the genomic enrichment of histone modifications was generally in accordance
with the expected patterns of histone modifications. During cell reprogramming, the
somatic cells assimilated into the epigenetic niche of ESCs. For the Hox D cluster genes,
which are sequentially expressed and play an important role in controlling the developmen-
tal stages, their peak patterns in iPSC1 and iPSC2 bore a close resemblance to those of
mESCs (Fig 1B). In cFB and sFB cells, the H3K4me3 enrichment was detected in the
Hoxd3, d8, and d9 genes, but in iPSCs and mESCs, almost all Hox D cluster genes showed
H3K4me3 enrichment. iPSCp1 still possessed some H3K4me3 peaks in Hox D cluster but
iPSC2, not. In contrast to iPSCs, the H3K4me3 patterns of iPSCp1 were similar to those of
the somatic cells, with some resemblance to somatic cells; for example, iPSCp1 had high lev-
els of H3K4me3 in the 5’ region of Hoxd3. The H3K27me3 enrichment in the Hox D cluster
was also reprogrammed during iPSC induction. A large amount of H3K27me3 level was
changed in both iPSCP1 and iPSCP2. The chromosome-wide peak patterns of H3K4me3
were shown using Hilbert plots in Fig 1C (chromosome 1 only) and S1 Fig (all chromo-
somes). The patterns of the iPSCs almost completely overlapped with the patterns of the
mESCs and were clearly different from those of their somatic origin cells, as expected. How-
ever, many peaks of mESC-iPSCp and iPSCp-sFB-G did not overlap with each other and
many of them appeared only in iPSCp, but not in mESC or sFB-G, indicating that iPSCp1
and iPSCp2 were not completely reprogrammed into pluripotent cells and were even diver-
gent from both mESC and sFB-G. The distributions of global histone modifications around
TSSs were compared and were not apparently distinguishable from each other (Fig 1D).
However, the differential enrichments of H3K4me3 in the gene body regions of somatic cells
(red box area) seemed to be assimilated into the epigenetic modification patterns of mESCs
by the induction of pluripotency, but those in iPSCp remained unchanged. The H3K27me3
profiles in cFB, sFB, and sFB-G showed much broader distributions and weaker enrichment
correlations, particularly in the H3K27me3-rich genes in mESCs and iPSCs. The H3K27me3
levels in iPSCp were closer to those of somatic cells. In detail, the Pearson correlation coeffi-
cients of H3K4me3 enrichment between the two cell types generally showed a highly positive
correlation (r > 0.8), suggesting that every genomic region was not totally different and that
only a small fraction had an aberrant level of H3K4me3 (S2A Fig). The highest linkage of
each pair was mESC-iPSC1 (r = 0.982) and the lowest one was iPSC1-sFB (r = 0.806). The
overall distributions of H3K27me3 correlations were widely dispersed and the levels were
low (S2B Fig). Their correlation coefficients were relatively smaller than those of H3K4me3,
Epigenome analysis during protein-based reprogramming
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Fig 1. Global histone modification signatures of pluripotent and somatic cells. (A) Experimental
overview of the genome-wide analysis of the histone modifications of mESC, iPSCs and the original somatic
cells using ChIP-Seq and their gene expression measured via microarray and RNA-seq. (B) The histone
modification profiles of the Hox D cluster genes are shown using the UCSC genome browser. The genomic
position of the region is indicated on top of the map. (C) Chromosome-wide H3K4me3 peak patterns are
compared in different cells. The Hilbert plots of H3K4me3 enrichments at chromosome 1 are visualized using
the HilberVis program. (D) The comparison of histone modification patterns between different mESCs and
iPSCs. The heatmap represents the distributions of the histone modification near the TSS of 22,086 RefSeq
Epigenome analysis during protein-based reprogramming
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but the ranks were similar to those of H3K4me3; the highest coefficients were from pairs of
mES and iPSCs, and the lowest coefficients were from pairs of mESC and somatic fibroblast
cells.
Gene expression program directed by histone modifications during cell
reprogramming
As reported by many previous studies, histone modifications are tightly correlated with
gene expression programs [14, 15]. To examine whether the dynamic changes in the gene
expression program were accompanied by alterations in histone methylation during cell
reprogramming, the gene expression and histone methylation levels were illustrated in the
color-coded scatter plots (Fig 2A–2F). Most genes shown in black were converged at the
center of each plot; thus, the histone modification and gene expression levels of iPSC1 and
iPSC2 were almost the same as those of the mESCs (Fig 2A and 2B). The number of genes
whose expression and histone modification levels were unchanged was approximately 98%
in the comparison of iPSCs with mESCs, and approximately only 1% of the genes were
either up-regulated or down-regulated (Fig 2A and 2B insets). In contrast, the two iPSCs
were far away from their somatic cells, supporting the hypothesis that the reprogramming
process completely transformed the cell types or lineages with respect to the gene expression
program and epigenetic status (Fig 2E and 2F). The percentages of up- or down-regulated
genes were increased to approximately 8% each; thus, 16.0% and 15.9% of the genes were
epigenetically reconstituted and differentially expressed in iPSC1 and iPSC2, respectively
(Fig 2E and 2F insets).
Many diverging genes were identified in the comparison between iPSCp and mESC, and
the overall profile was completely different from those shown in Fig 2A or 2B. Both iPSCp1
and iPSCp2 seemed closer to their somatic cells regarding epigenetic behavior and transcrip-
tion levels (Fig 2G and 2H). Only 87.1% of the iPSCp1 genes maintained similar expression
levels to mESC, and 12.9% of genes were up- or down-regulated. Interestingly, iPSCp2 showed
higher similarity to mESC (96.9%, Fig 2D). Compared to sFB-G, the iPSCp1 showed 93.4%
similarity of gene expression and histone modification levels. This gene-wide comparison
between iPSCp and mESC revealed that the histone modification and gene expression levels
of many genes were not consistent with each other, raising the possibility of divergent cell
reprogramming.
Focusing on the key transcription factors involved in stem cell maintenance, such as
Nanog, Sox2, Oct4, and Klf4, there was little difference between iPSC and mESC in both his-
tone modifications and expression levels (Fig 2I and S3 Fig). During reprogramming, the
H3K4me3 levels and expression of these genes in iPSC1 were increased, whereas the
H3K27me3 levels were decreased. It is worth noting that in iPSCp1, the transcriptional repro-
gramming of Oct4 and Nanog was not induced because they were still buried in the repressive
chromatin region enriched with H3K27me3 (Fig 2G and S4 Fig). Interestingly, in iPSCp1,
Sox2 was highly methylated at histone H3K4; accordingly, its expression level was also up-reg-
ulated. Constrast to iPSCp1, iPSCp2 showed partial histone modification chages and mRNA
levels of key transcription factors almost reached the level of iPSCs, suggesting that iPCP2
might be at the later stage of reprogramming.
genes. The rows in the all data sets are sorted using the tag density of the mESCs from the highest to the
lowest. The position of the TSS and the direction of transcription are denoted using an arrow. The numbers
inside the heatmap indicate the Pearson correlation coefficients compared with the mESCs.
doi:10.1371/journal.pone.0171300.g001
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Differential analysis of the genes aberrantly expressed in iPSCs
As shown in Figs 1 and 2, the protein-based iPSC and mESC were indistinguishable with
respect to their epigenetic patterns and expression programs. To further assess the identity of
iPSC after the cell reprogramming process, the gene expression profile of iPSC1 was compared
Fig 2. Characterization of epigenetic signatures related to gene expression in iPSCs. (A-F). The scatter plots show the fold
changes in H3K4me3, H3K27me3, and gene expression during reprogramming. Each dot represents a gene with p-value less than
0.01. The X and Y axes indicate the fold changes in H3K4me3 and H3K27me3 (log2 scale), respectively. The color code shows the
gene expression level from low to high (green-black-red). The percentage of differentially expressed genes is shown in the inset pie
chart (ANOVA test p-value<0.01, fold change>2). (G) The chromatin states of the key transcription factor genes, such as the Oct4,
Nanog, and Sox2, are shown on the UCSC genome browser.
doi:10.1371/journal.pone.0171300.g002
Epigenome analysis during protein-based reprogramming
PLOS ONE | DOI:10.1371/journal.pone.0171300 February 2, 2017 8 / 18
with other publicly available iPSC data (Fig 3A). The relative similarity of the gene expression
profiles among cell types was calculated using the hierarchical clustering analysis. The distance
between iPSCs and somatic cells was the longest of the two large groups and was separated
using a dotted line (node height = 186.57); pairs of iPSCs and mESCs cultured in the same lab-
oratory were closely located (marked by grey boxes, node height< 75), indicating that the
somatic cells and culture conditions of the iPSCs from different laboratories might lead to this
minor divergence in the gene expression program, as considered in previous reports [38, 39].
Even the four transcription factor-driven (OSKM; Oct4, Sox2, Klf4, and c-Myc) iPSCs from
two independent groups [50, 51] were positioned in different places on the hierarchical clus-
tering of gene expression (node height = 94.74). Moreover, all mESCs were not clustered with
each other, but were individually located next to each iPSC with which a research group main-
tains the mESCs. The gene expression levels of the iPSCs were broadly comparable. However,
to examine how similar the iPSCs from different laboratories are or if the differences might be
negligible, the differentially expressed genes (DEGs) of iPSCs relative to mESCs were com-
pared; the common DEGs in iPSC1 and iPSC2 occupied only 6.9% (19/274) of the up-regu-
lated genes and 3.6% (10/274) of the down-regulated genes (Fig 3B and 3C). Compared with
the public data sets, there were no common DEGs among iPSC1, iPSC2, iPSC [50], and iPSC§
Fig 3. Comparative analysis of the protein-based iPSCs and other pluripotent cells. (A) Hierarchical clustering of the gene
expression microarray data for the mESCs (open circles), iPSCs (filled circles), and fibroblasts (filled squares) from different
laboratories. The data sets of the mESCs and iPSCs obtained from the same laboratory are marked using grey boxes. The iPSC
induction methods are labelled for each iPSC data set: 1GSE13770, 2GSE24930, 3GSE17004, 4GSE27814, 5GSE22908,
6GSE24046, and 7GSE27087. (B-C) The Venn diagram shows the overlap of the differentially expressed genes between mESCs and
iPSCs. For comparison, two iPSC* (GSE24046) and iPSC§ (GSE27814) data sets are also incorporated. (D) The gene expression
levels and histone modifications of the differentially expressed genes defined in (B-C) are shown and the Pearson correlation
coefficients are presented on the right side of each heatmap.
doi:10.1371/journal.pone.0171300.g003
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[48]. A further examination of the histone modification levels of the DEGs revealed that the
DEGs in iPSC2 but not in iPSC1 showed expression levels corresponding to the histone modi-
fication changes; the correlation was higher in iPSC2 than in iPSC1 (Fig 3D). In the compari-
son of somatic cells with mESCs, the fold changes in expression were well-correlated with the
alterations in the histone modification levels. There was almost no correlation of the histone
modification levels and the gene expression levels of mESCs vs. iPSC1, implying that the
expression of these minor genes might not be affected by H3K4me3 and H3K27me3. A rela-
tively good correlation of mRNA expression and histone modification levels was observed in
iPSCps and in its somatic cell, sFB-G, where the expression levels of many genes reflect the
degree of histone modifications. The differentially expressed genes are annotated in S4 Fig.
The highly expressed genes of iPSCs were involved in RNA processing and splicing, mRNA/
DNA metabolic process, ribonucleoprotein complex biogenesis, and chromosome organiza-
tion. The fibroblast-specific genes were down-regulated and were associated with cell
adhesion, vasculature development, blood vessel development, and extracellular matrix orga-
nization. These significant biological functions that were associated with the up- or down-reg-
ulated genes of iPSCs were also compatible with mESC-specific functions.
Early and late responder genes identified from a comparative analysis of
partial iPSCs and mESCs
iPSC1 and iPSC2 were almost identical to mESCs at the transcriptional and epigenetic levels,
with minor variations. The comparison of the histone modification and gene expression levels
of the iPSCp1 with those of mESCs displayed a deep disparity. A further comparative analysis
led to the categorization of differentially expressed genes into three groups: the divergent, the
convergent, and the resistant genes (Fig 4A and S1–S6 Tables). Among the 2,554 differentially
expressed genes in the mESCs compared to sFB-G (1,250 down-regulated and 1,304 up-regu-
lated genes in the mESCs), 255 up-regulated genes were also increased in the iPSCp1, and 431
down-regulated genes were also decreased in the iPSCp1; these were called the “convergent”
or the “early responder” genes before the start of pluripotency because the expression levels of
these genes in iPSCp1 were comparable to the expression levels in the mESCs. The 226 up-reg-
ulated and 118 down-regulated genes in iPSCp1 vs. sFB-G were regarded as “divergent” genes
because only iPSCp-specific regulated genes fell into this category. The third category was the
“resistant” or the “late responder” genes, which were up- or down-regulated in mESC but not
in iPSCp. The correlation coefficient was also calculated for the gene expression levels between
mESC/sFB-G and iPSCp/sFB-G and was r = 0.546 for the down-regulated genes and r = 0.037
for the up-regulated genes, indicating that, in the partial iPSC, the expression of somatic cell-
specific genes was efficiently repressed and that ESC-specific genes were activated during
reprogramming.
As shown in Fig 4A, among the up-regulated genes in iPSCp1 and mESC relative to sFB-G,
the average H3K4me3 level of the divergent genes was the highest in iPSCp1 and those of con-
vergent and resistant genes were higher in pluripotent cells, such as mESC, iPSC1, and iPSC2,
than in iPSCp1 and sFB-G (Fig 4B). The H3K27me3 level was positively correlated with the
down-regulation of gene expression, such that among the down-regulated genes in iPSCp1
and mESC compared with sFB-G, the convergent and resistant gene groups had higher
H3K27me3 levels in the pluripotent cells, but not in iPSCp1 and sFB-G. In iPSCp1, the diver-
gent genes contained more H3K27me3 marks than the convergent or resistant genes.
As examples of these categories, both fibroblast growth factor 5 (Fgf5) and Sox2 were
marked only by H3K27me3 in sFB-G. The Fgf5 gene belongs to the divergent gene group pos-
sessed high enrichment of H3K4me3 and a high level of expression in only iPSCp1, but not
Epigenome analysis during protein-based reprogramming
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mESC (Fig 4C and S5 Fig). Sox2 was transcriptionally reprogrammed as de-differentiation was
induced, and its H3K4me3 level was high in iPSCp; therefore, Sox2 could be classified as an
early responder gene (Fig 2G). The epigenetic state and expression of the collagen type 1 alpha
1 (Col1a1) gene in iPSCp1 were not affected by pluripotency induction, and it was one of the
resistant genes. Cell division cycle protein 20 (Cdc20) maintained a high level of H3K4me3
and expression before and after induction (Fig 4C and S5 Fig).
The biological functions of the divergent, convergent and resistant genes grouped using the
propensity of fibroblast cells to obtain pluripotency revealed the following features (Fig 4D
and S1–S7 Tables): many divergent genes were associated with organ development, such as
dendrite, muscle, neuron, and gland, and many divergent genes were significantly involved in
cytoskeleton and cancer-related pathways (S7 Table); these results imply that this iPSCp was
far away from iPSCs and thereby partially differentiated. However, the convergent genes were
connected with stem cell-related functions and could be regarded as early responder genes on
the pathway from fibroblasts to iPSCs. From the gene ontology analysis of the convergent
genes, the most significant biological functions were cell cycle, M phase, DNA metabolic pro-
cess, and cell division (Fig 4D). The resistant genes, which were detected only in the mESCs
but not in our iPSCps, might be late responder genes that are turned on or off at the last step of
the reprogramming process. The resistant or late responder genes were linked to RNA pro-
cessing, splicing, and metabolic process (Fig 4D). These three group genes were further com-
pared with other published data (S6 Fig). The similar degree of differences between iPSCp1
Fig 4. Identification of early and late responder genes from the partial iPSC analysis. (A) Categorization of the differentially
expressed genes among iPSCps, mESCs, and sFB-G into three groups: the divergent, the convergent, and the resistant genes. (B)
The H3K4me3 and H3K27me3 levels were plotted, depending on the responsiveness of the genes to the induction of pluripotency (C)
The UCSC genome browser shows the chromatin states of the divergent (Fgf5), convergent (Cdc20), and resistant (Col1a1) genes in
all cell types. The positions and directions of transcription of the genes are indicated below the panel. (D) The three groups are listed
according to their expression and histone modification fold change values. The gene ontology analysis shows highly significant
biological functions associated with the differentially expressed genes. (E) A model for the step-wise acquisition of pluripotency. Sox2
was identified as an early responder gene.
doi:10.1371/journal.pone.0171300.g004
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and iPSCp2 was also detected in the comparison among iPSCp1, MCV6 and MCV8. The num-
ber of genes showing over 2-fold differences in gene expression was increased in resistant gene
group during Dox-induced iPSC generation. Together, these results indicate that the iPSCps
seem to have partial cellular potency and a cancer cell-like capability.
Discussion
The aim of this study was to characterize the epigenetic status of protein-based iPSCs and to
identify the responder genes during the induction of pluripotency by comparing iPSCs with
partial iPSCs. We extracted soluble proteins from mouse ESCs on the C57BL/6 background
and used them to induce pluripotency. These protein-based iPSCs were easy to generate,
highly efficient, and their potential safety has already been validated [7]. The analysis of dif-
ferential proteomes using Isobaric Tags for Relative and Absolute Quantification (iTRAQ)
technique identified 1,883 proteins in iPSCs. Among them, 225 differentially expressed pro-
teins were determined; they were mainly associated with the regulation of protein synthesis
and metabolism, suggesting that there is a threshold that protein synthetic machinery
must exceed to initiate reprogramming [45]. Here, we have mapped two major histone mod-
ifications involved in the determination of cell types and development, H3K4me3 and
H3K27me3, of two types of iPSCs, partial iPSCs, and adult origin fibroblasts, as well as ESCs,
which were used as a reference. The overall epigenetic profiles and gene expression data
of iPSCs were almost indistinguishable from those of ESCs (Figs 1 and 2, S1 Fig). The
H3K4me3 enrichment around TSSs was a bit broader in cFB and sFB than in iPSCs and
ESCs, indicating that the active genes in the pluripotent cells are marked by high levels of
active histone modifications at narrow regions and clearly separated from inactive genes (Fig
1D). These results are consistent with the tendency toward an overall increase in the active
histone modification levels, such as H3K4me3, at the active loci in ESCs and iPSCs, but
almost no changes in the cellular H3K27me3 levels between the somatic cells and pluripotent
cells [44]. The hierarchical clustering of somatic and pluripotent cells indicates that the
iPSCs were grouped with ESCs, depending on where the cells were maintained rather than
the cell line origin (Fig 3A). There were no common genes detected that could account for
the minor differences between our iPSCs and other groups’ iPSCs (Fig 3B and 3C). The com-
parison of the DNA methylation and gene expression levels revealed that there were more
cell-line-specific outliers in iPSCs than in ESCs, despite their global similarity [41]. This
handful of disparities may have important practical implications, such as the validation of a
large number of iPSC lines and the continuous monitoring of cell line quality. However, as
shown in Fig 3 and other groups’ reports [38, 39], the discrepancy seems to be largely depen-
dent on the laboratory or specificity of the original cell line. The uncontrolled laboratory-
specific variables and the cell passage-dependent changes caused by minutely different cul-
ture environments are also expected to contribute to the differential gene expression levels
that were observed.
Interestingly, we observed distinct signatures that distinguish partial iPSCs from fully
reprogrammed iPSCs. The Sox2 gene was reprogrammed prior to the expression of other plur-
ipotency genes, such as Oct4 and Nanog, in the iPSCps. Other partial iPSCs are also known to
fail to express many endogenous pluripotency genes, including Oct4 and Nanog [52]. Sox2 is
known to be one of several genes that are highly expressed in pluripotent cell lines with rela-
tively low variation [41] and are not regulated by DNA methylation, whereas the pluripotency
regulators, such as Oct4 and Nanog, are repressed through DNA hypermethylation in somatic
cells [19, 43]. Different from the conventional iPSC technology based on viral transduction of
key transcription factors, where the initial induction of exogenous Oct4 and Nanog is usually
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observed at the early reprogramming stage, our protein-based iPSC approach might trigger
the expression of endogenous Sox2 at early stage and sequentially followed by other factors (S3
Fig). There are three groups of differentially expressed genes identified using the comparison
between iPSCp/sFG-G and mESC/sFB-G (Fig 4A). The divergent genes have different expres-
sion patterns from both somatic cells and mESCs and most of them are associated with func-
tions in organ development. The KEGG (Kyoto Encyclopedia of Genes and Genomes)
pathway analysis revealed that many divergent genes were associated with several cancer types
(S7 Table). The expression levels of the convergent genes are perturbed at the early stage of
reprogramming and eventually reach the range of the ES-specific gene expression program.
The resistant genes in our iPSCps are not turned on or off but they should be regulated to
become fully reprogrammed into the pluripotent state at the last step of the reprogramming
process. The existence of divergent and resistant genes in the iPSCps might be an obstacle to
complete cell reprogramming and may cause tumorigenicity when incomplete iPSCs are used
in the clinic. We identified the tumorigenic potential of our iPSCps and showed that the in
vivo use of the iPSCps in a mouse led to tumor formation (data not shown). Consistent with a
previous report [42], the down-regulation of somatic cell-specific genes occurred more effi-
ciently in the iPSCps than the up-regulation of ESC-specific genes, as deduced from the higher
correlation value of mESC/sFB-G and iPSCp/sFB-G in somatic cell-specific genes (0.546) than
in ESC-specific genes (0.037).
Based on these results, we suggest that the cellular reprogramming was accompanied by the
step-wise alterations of the epigenetic status to reach a pluripotent status (Fig 4E). In this
model, the iPSCs could be formed by pathway I and II in a step-wise manner. For some reason,
the somatic cells could not overcome the threshold of pluripotency and remained at an oligo-
potent or multipotent stage in only pathway I. The iPSCps of this study did not have the
middle stage between the somatic fibroblasts and the mESCs, and they also expressed some
divergent gene groups. These iPSCps might be obtained using pathway III alone or a combina-
tion of pathways I and IV. The divergent gene group should determine the cellular fate of
iPSCps regarding differentiation and tumorigenic potency.
When the cell reprogramming process is complete, the epigenetic signatures and gene
expression programs are almost identical to those of ESCs. Our protein-based iPSC induc-
tion method using ESC soluble proteins can successfully establish iPSC lines that are almost
indistinguishable from the ESCs epigenetically. The differences between protein-based
iPSCs and ESCs may occur at similar or lower levels than other iPSC induction methods,
but seemingly do not lead to significant functional differences. Importantly, the assessment
of partial iPSCs provides more convincing evidence that the reprogramming process
should undergo a step-wise transition that is tightly controlled by the early and the late
responder genes in response to the induction signal during reprogramming. Taken together,
our results indicate that cell fate determination should be accompanied by accurate epige-
netic changes.
Conclusions
The epigenetic characterization of protein-based iPSCs and partial iPSCs compared with
fibroblasts and mESCs revealed several features. The iPSCs were almost epigenetically and
transcriptionally identical to the mESCs, with negligible discrepancies. A comparative
study of the partial iPSCs indicated that cellular reprogramming to generate iPSCs requires
a step-wise epigenetic acquisition of pluripotency. The responsiveness of the cells to the
induction of pluripotency should be determined by the presence of early (convergent) and
late (resistant) responder genes in the pathway from fibroblasts to iPSCs. The potential
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tumorigenicity of iPSCs might be caused by incomplete reprogramming, during which
the third group of divergent genes were dysregulated to a larger extent. In summary, the
genome-wide comparison could suggest more convincing evidence that complete transcrip-
tional reprogramming should be accompanied by faithful epigenetic changes in a step-wise
manner and the cells’ responsiveness to external stimuli should be properly regulated to pre-
vent unwanted reprogramming.
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